Reference
Health Canada. ULORIC (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes. Internet Document : 4 Nov 2019. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71511a-eng.php
Rights and permissions
About this article
Cite this article
Increased risk of CV-related death with febuxostat. Reactions Weekly 1779, 2 (2019). https://doi.org/10.1007/s40278-019-71266-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-71266-z